Multi-omics profiling and molecular pathways in esophageal adenocarcinoma.

Esophageal adenocarcinoma (EAC) is an aggressive malignancy with a rising incidence and poor prognosis. This review integrates current insights into the molecular features of EAC, focusing on the application of multi-omics approaches to unravel its genetic, transcriptomic, metabolic, and microenvironmental alterations. By identifying key biomarkers and therapeutic targets, we highlight the transformative potential of multi-omics in advancing precision medicine for EAC.